Assessment
Questionnaire
See what questions
a doctor would ask.
A gene company therapy has developed a drug called Advexin which, when used with chemotherapy prior to surgery, causes tumors to shrink by at least 50%. This potentially makes the surgery less invasive and more effective. Early trial results indicate that it is very successful. Patients with advanced breast cancer are particularly benefited by this tumor reduction therapy.
Source: summary of medical news story as reported by Reuters Health
About: New Advexin tumor shrinking drug developed
Date: 9 December 2004
Source: Reuters Health
URL:
http:/ This summary article refers to the following medical categories:
Tools & Services:
Medical Articles:
Related Medical Topics
More News Topics
» Next page: New age for prescriptions
Medical Tools & Articles:
Forums & Message Boards
Search Specialists by State and City
By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.
Copyright © 2011 Health Grades Inc. All rights reserved. Last Update: 6 May, 2013 (23:55)